Develops and manufactures a diverse range of prescription drugs across various therapeutic areas. Offers a wide selection of over-the-counter (OTC) healthcare products. Now — the numbers.
This is an established company with proven profits.
Red columns mark years that ended in a loss.
The gap is $275.7M. In times of high interest rates, a gap like that can squeeze a company.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Our checks did not surface a specific strength to highlight here.
The stock sits at $0.0001. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 56.2 times as much as the market average. Big rallies — and big drops — can both happen fast.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.